Headlines | WebDisclosure

BRIEF

published on 09/13/2024 at 14:15, 14 minutes ago

Kalray Annonce la Publication de ses Résultats Semestriels 2024

Résultats Semestriels Stratégie De Développement Investisseurs Négociations Kalray
BRIEF

published on 09/13/2024 at 14:15, 14 minutes ago

Kalray Announces the Publication of its 2024 Half-Year Results

Investors Negotiations Half-year Results Development Strategy Kalray
PRESS RELEASE

published on 09/13/2024 at 14:15, 14 minutes ago

INFORMATION ON 2024 HALF-YEAR RESULTS
Kalray announces the upcoming publication of its 2024 half-year results on September 19, 2024, and a meeting with the financial community on September 20. The company will review results, strategy, and outlook post negotiations with Pliops

Exclusive Negotiations Kalray Data Acceleration 2024 Half-year Results Financial Community Meeting
PRESS RELEASE

published on 09/13/2024 at 14:10, 19 minutes ago

PUBLICATION DES RÉSULTATS SEMESTRIELS 2024
Kalray annonce la diffusion de son prochain communiqué de presse sur ses résultats semestriels 2024 le 19 septembre 2024 après Bourse. La réunion d'information aux actionnaires est prévue pour le 20 septembre

Actionnaires Communiqué De Presse Kalray Résultats Semestriels 2024 Réunion D'information
BRIEF

published on 09/13/2024 at 14:02, 26 minutes ago

CureVac's CVGBM Cancer Vaccine Shows Promising Results in Phase 1 Glioblastoma Study

CureVac Glioblastoma CVGBM Phase 1 Study T-cell Responses
BRIEF

published on 09/13/2024 at 14:02, 26 minutes ago

Le vaccin contre le cancer CVGBM de CureVac montre des résultats prometteurs dans une étude de phase 1 sur le glioblastome

Étude De Phase 1 CureVac Glioblastome CVGBM Réponses Des Lymphocytes T
PRESS RELEASE

published on 09/13/2024 at 13:57, 31 minutes ago

CureVac’s CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress
CureVac's CVGBM Cancer Vaccine induces promising immune responses in Phase 1 Study in Glioblastoma presented at ESMO 2024 Congress. Results show de novo T-cell activity & acceptable safety profile up to 100 µg dose

Cancer Vaccine CureVac CVGBM Phase 1 Study Immune Responses
BRIEF

published on 09/13/2024 at 13:50, 39 minutes ago

Galloper Gold Commences Diamond Drilling at Glover Island

Gold Exploration Diamond Drilling Copper Anomaly Galloper Gold Corp Glover Island
BRIEF

published on 09/13/2024 at 13:50, 39 minutes ago

Galloper Gold commence le forage au diamant sur l'île Glover

Exploration Aurifère Forage Au Diamant Anomalie Du Cuivre Galloper Gold Corp Île Glover
PRESS RELEASE

published on 09/13/2024 at 13:45, 44 minutes ago

Galloper Gold Commences Diamond Drilling at Glover Island
Galloper Gold Corp. commences Phase 1 diamond drilling at Glover Island Project in Western Newfoundland, targeting gold and copper anomalies. CEO excited about new discovery opportunities

Gold Deposits Galloper Gold Corp. Phase 1 Diamond Drilling Glover Island Project Western Newfoundland

Published on 09/13/2024 at 13:45, 44 minutes ago

Galloper Gold Commences Diamond Drilling at Glover Island
Published on 09/13/2024 at 04:10, 10 hours 19 minutes ago

The Sukhothai Spa at the Sukhothai Bangkok Unveils a Tranquil Oasis in the Heart of the City
Published on 09/13/2024 at 02:10, 12 hours 19 minutes ago

Anson Receives Final Approval for Brine Extraction at its Green River Lithium Project
Published on 09/12/2024 at 23:25, 15 hours 4 minutes ago

Xebra Brands Announces Warrant Extension
Published on 09/12/2024 at 23:16, 15 hours 13 minutes ago

Augusta Precious Metals Review Guide Released: Highlights Fees, Ratings, and Customer Feedback

View all ACCESSWIRE

Published on 09/13/2024 at 13:57, 31 minutes ago

CureVac’s CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress
Published on 09/13/2024 at 13:35, 54 minutes ago

Appointment of Angus Barker and Board evolution
Published on 09/13/2024 at 11:20, 3 hours 8 minutes ago

FP discontinues project to introduce a standardised ERP/CRM system
Published on 09/13/2024 at 11:19, 3 hours 10 minutes ago

KION Group Supports Endowed Professorship for AI Solutions at TU Dortmund University
Published on 09/13/2024 at 11:00, 3 hours 29 minutes ago

FUCHS SE signs letter of intent to acquire Swiss lubricant company STRUB & Co. AG

View all EQS

Published on 09/13/2024 at 08:31, 5 hours 57 minutes ago

Mandat de rachat d’actions
Published on 09/13/2024 at 08:31, 5 hours 57 minutes ago

Share buyback mandate
Published on 09/12/2024 at 20:41, 17 hours 48 minutes ago

ASSEMBLEE GENERALE DU 10 SEPTEMBRE 2024 : COMPTE-RENDU ET RESULTATS DES VOTES
Published on 09/12/2024 at 18:00, 20 hours 29 minutes ago

SMTPC_Communiqué sur le Chiffre d'affaires du 1er semestre 2024
Published on 09/12/2024 at 17:45, 20 hours 44 minutes ago

DAMARTEX / Droits de vote bruts et réels 31 août 2024

View all LES ECHOS COMFI WIRE

News